Catecholamine predictors of complicated grief treatment outcomes

Mary-Frances O'Connor, M. Katherine Shear, Rachel Fox, Natalia Skritskaya, Bevin Campbell, Angela Ghesquiere, Kim Glickman

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Could sympathetic hyperarousal limit treatment success in complicated grief? The present study investigated persons with complicated grief, a chronic condition with distinct symptoms including persistent intense yearning and longing for the person who died, avoidance of reminders that the person is gone, deep relentless sadness, self-blame, bitterness, or anger in connection with the death, and an inability to gain satisfaction or joy through engaging in meaningful activities or relationships with significant others. Length of bereavement did not correlate with complicated grief scores. Catecholamines (i.e., epinephrine, norepinephrine, dopamine) in plasma were assessed pre- and post-psychotherapeutic treatment. Participants with the highest levels of epinephrine at pre-treatment had the highest levels of complicated grief symptoms at post-treatment, accounting for baseline levels of symptoms. This predictive relationship was not seen for depressive symptoms. The present study supports the hypothesis that catecholamine levels are affected by bereavement, and in turn, can affect the ability of those with complicated grief to benefit from psychotherapy.

Original languageEnglish (US)
Pages (from-to)349-352
Number of pages4
JournalInternational Journal of Psychophysiology
Volume88
Issue number3
DOIs
StatePublished - Jun 2013

Fingerprint

Grief
Catecholamines
Bereavement
Epinephrine
Aptitude
Anger
Psychotherapy
Dopamine
Norepinephrine
Depression

Keywords

  • Bereavement
  • Catecholamines
  • Dopamine
  • Epinephrine
  • Grief
  • Norepinephrine
  • Psychotherapy

ASJC Scopus subject areas

  • Neuroscience(all)
  • Physiology (medical)
  • Neuropsychology and Physiological Psychology

Cite this

O'Connor, M-F., Shear, M. K., Fox, R., Skritskaya, N., Campbell, B., Ghesquiere, A., & Glickman, K. (2013). Catecholamine predictors of complicated grief treatment outcomes. International Journal of Psychophysiology, 88(3), 349-352. https://doi.org/10.1016/j.ijpsycho.2012.09.014

Catecholamine predictors of complicated grief treatment outcomes. / O'Connor, Mary-Frances; Shear, M. Katherine; Fox, Rachel; Skritskaya, Natalia; Campbell, Bevin; Ghesquiere, Angela; Glickman, Kim.

In: International Journal of Psychophysiology, Vol. 88, No. 3, 06.2013, p. 349-352.

Research output: Contribution to journalArticle

O'Connor, M-F, Shear, MK, Fox, R, Skritskaya, N, Campbell, B, Ghesquiere, A & Glickman, K 2013, 'Catecholamine predictors of complicated grief treatment outcomes', International Journal of Psychophysiology, vol. 88, no. 3, pp. 349-352. https://doi.org/10.1016/j.ijpsycho.2012.09.014
O'Connor, Mary-Frances ; Shear, M. Katherine ; Fox, Rachel ; Skritskaya, Natalia ; Campbell, Bevin ; Ghesquiere, Angela ; Glickman, Kim. / Catecholamine predictors of complicated grief treatment outcomes. In: International Journal of Psychophysiology. 2013 ; Vol. 88, No. 3. pp. 349-352.
@article{42c0984bb05848e5890d1e0808147c60,
title = "Catecholamine predictors of complicated grief treatment outcomes",
abstract = "Could sympathetic hyperarousal limit treatment success in complicated grief? The present study investigated persons with complicated grief, a chronic condition with distinct symptoms including persistent intense yearning and longing for the person who died, avoidance of reminders that the person is gone, deep relentless sadness, self-blame, bitterness, or anger in connection with the death, and an inability to gain satisfaction or joy through engaging in meaningful activities or relationships with significant others. Length of bereavement did not correlate with complicated grief scores. Catecholamines (i.e., epinephrine, norepinephrine, dopamine) in plasma were assessed pre- and post-psychotherapeutic treatment. Participants with the highest levels of epinephrine at pre-treatment had the highest levels of complicated grief symptoms at post-treatment, accounting for baseline levels of symptoms. This predictive relationship was not seen for depressive symptoms. The present study supports the hypothesis that catecholamine levels are affected by bereavement, and in turn, can affect the ability of those with complicated grief to benefit from psychotherapy.",
keywords = "Bereavement, Catecholamines, Dopamine, Epinephrine, Grief, Norepinephrine, Psychotherapy",
author = "Mary-Frances O'Connor and Shear, {M. Katherine} and Rachel Fox and Natalia Skritskaya and Bevin Campbell and Angela Ghesquiere and Kim Glickman",
year = "2013",
month = "6",
doi = "10.1016/j.ijpsycho.2012.09.014",
language = "English (US)",
volume = "88",
pages = "349--352",
journal = "International Journal of Psychophysiology",
issn = "0167-8760",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Catecholamine predictors of complicated grief treatment outcomes

AU - O'Connor, Mary-Frances

AU - Shear, M. Katherine

AU - Fox, Rachel

AU - Skritskaya, Natalia

AU - Campbell, Bevin

AU - Ghesquiere, Angela

AU - Glickman, Kim

PY - 2013/6

Y1 - 2013/6

N2 - Could sympathetic hyperarousal limit treatment success in complicated grief? The present study investigated persons with complicated grief, a chronic condition with distinct symptoms including persistent intense yearning and longing for the person who died, avoidance of reminders that the person is gone, deep relentless sadness, self-blame, bitterness, or anger in connection with the death, and an inability to gain satisfaction or joy through engaging in meaningful activities or relationships with significant others. Length of bereavement did not correlate with complicated grief scores. Catecholamines (i.e., epinephrine, norepinephrine, dopamine) in plasma were assessed pre- and post-psychotherapeutic treatment. Participants with the highest levels of epinephrine at pre-treatment had the highest levels of complicated grief symptoms at post-treatment, accounting for baseline levels of symptoms. This predictive relationship was not seen for depressive symptoms. The present study supports the hypothesis that catecholamine levels are affected by bereavement, and in turn, can affect the ability of those with complicated grief to benefit from psychotherapy.

AB - Could sympathetic hyperarousal limit treatment success in complicated grief? The present study investigated persons with complicated grief, a chronic condition with distinct symptoms including persistent intense yearning and longing for the person who died, avoidance of reminders that the person is gone, deep relentless sadness, self-blame, bitterness, or anger in connection with the death, and an inability to gain satisfaction or joy through engaging in meaningful activities or relationships with significant others. Length of bereavement did not correlate with complicated grief scores. Catecholamines (i.e., epinephrine, norepinephrine, dopamine) in plasma were assessed pre- and post-psychotherapeutic treatment. Participants with the highest levels of epinephrine at pre-treatment had the highest levels of complicated grief symptoms at post-treatment, accounting for baseline levels of symptoms. This predictive relationship was not seen for depressive symptoms. The present study supports the hypothesis that catecholamine levels are affected by bereavement, and in turn, can affect the ability of those with complicated grief to benefit from psychotherapy.

KW - Bereavement

KW - Catecholamines

KW - Dopamine

KW - Epinephrine

KW - Grief

KW - Norepinephrine

KW - Psychotherapy

UR - http://www.scopus.com/inward/record.url?scp=84884163272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884163272&partnerID=8YFLogxK

U2 - 10.1016/j.ijpsycho.2012.09.014

DO - 10.1016/j.ijpsycho.2012.09.014

M3 - Article

VL - 88

SP - 349

EP - 352

JO - International Journal of Psychophysiology

JF - International Journal of Psychophysiology

SN - 0167-8760

IS - 3

ER -